

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.45086143 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.27201774 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.27201774 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.20456772 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.04470616 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.04470616 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.81292344 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 3.80765494 |
| 9 | immunoglobulin mediated immune response (GO:0016064) | 3.75044210 |
| 10 | definitive hemopoiesis (GO:0060216) | 3.70650657 |
| 11 | cellular extravasation (GO:0045123) | 3.66839254 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.49226948 |
| 13 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.36511674 |
| 14 | daunorubicin metabolic process (GO:0044597) | 3.35543851 |
| 15 | polyketide metabolic process (GO:0030638) | 3.35543851 |
| 16 | doxorubicin metabolic process (GO:0044598) | 3.35543851 |
| 17 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.34396930 |
| 18 | negative regulation of T cell mediated immunity (GO:0002710) | 3.33262863 |
| 19 | regulation of antigen processing and presentation (GO:0002577) | 3.32077435 |
| 20 | response to peptidoglycan (GO:0032494) | 3.27546409 |
| 21 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.20690676 |
| 22 | response to interferon-alpha (GO:0035455) | 3.18058955 |
| 23 | negative thymic T cell selection (GO:0045060) | 3.14447825 |
| 24 | negative T cell selection (GO:0043383) | 3.11473669 |
| 25 | detection of bacterium (GO:0016045) | 3.08207349 |
| 26 | defense response to protozoan (GO:0042832) | 3.07789271 |
| 27 | T cell migration (GO:0072678) | 3.04732364 |
| 28 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.04550366 |
| 29 | B cell receptor signaling pathway (GO:0050853) | 3.04150078 |
| 30 | positive regulation of mast cell activation (GO:0033005) | 3.03524472 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00600147 |
| 32 | regulation of interferon-alpha production (GO:0032647) | 2.99845532 |
| 33 | positive regulation of interferon-alpha production (GO:0032727) | 2.98864939 |
| 34 | cellular response to interleukin-15 (GO:0071350) | 2.97983672 |
| 35 | response to protozoan (GO:0001562) | 2.96203660 |
| 36 | interferon-gamma production (GO:0032609) | 2.96102757 |
| 37 | positive regulation of defense response to virus by host (GO:0002230) | 2.96060904 |
| 38 | negative regulation of interleukin-6 production (GO:0032715) | 2.95700327 |
| 39 | regulation of mast cell activation (GO:0033003) | 2.92620364 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 2.91237445 |
| 41 | activated T cell proliferation (GO:0050798) | 2.90290457 |
| 42 | response to interleukin-15 (GO:0070672) | 2.89537650 |
| 43 | lymph vessel development (GO:0001945) | 2.88945889 |
| 44 | B cell mediated immunity (GO:0019724) | 2.85816164 |
| 45 | * regulation of T cell mediated cytotoxicity (GO:0001914) | 2.85297798 |
| 46 | tolerance induction (GO:0002507) | 2.84442347 |
| 47 | macrophage activation (GO:0042116) | 2.84096270 |
| 48 | regulation of regulatory T cell differentiation (GO:0045589) | 2.83876788 |
| 49 | neutrophil activation (GO:0042119) | 2.83299968 |
| 50 | valine metabolic process (GO:0006573) | 2.81254738 |
| 51 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.80838729 |
| 52 | * positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.78695745 |
| 53 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.78097552 |
| 54 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.77814540 |
| 55 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.77814540 |
| 56 | leukocyte aggregation (GO:0070486) | 2.74602389 |
| 57 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.73451464 |
| 58 | regulation of tolerance induction (GO:0002643) | 2.73287720 |
| 59 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.72519376 |
| 60 | granulocyte activation (GO:0036230) | 2.70463216 |
| 61 | regulation of T cell tolerance induction (GO:0002664) | 2.69482236 |
| 62 | positive thymic T cell selection (GO:0045059) | 2.67691052 |
| 63 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.67288314 |
| 64 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.66788455 |
| 65 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.65705881 |
| 66 | regulation of natural killer cell differentiation (GO:0032823) | 2.65094781 |
| 67 | cellular response to exogenous dsRNA (GO:0071360) | 2.64687256 |
| 68 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.63941838 |
| 69 | negative regulation of innate immune response (GO:0045824) | 2.61115862 |
| 70 | xenobiotic catabolic process (GO:0042178) | 2.59387833 |
| 71 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.57810742 |
| 72 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.57716693 |
| 73 | response to host (GO:0075136) | 2.57716693 |
| 74 | response to host defenses (GO:0052200) | 2.57716693 |
| 75 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.56935369 |
| 76 | phagocytosis, engulfment (GO:0006911) | 2.56722018 |
| 77 | regulation of hypersensitivity (GO:0002883) | 2.55722755 |
| 78 | negative regulation of lipid storage (GO:0010888) | 2.54341910 |
| 79 | regulation of mast cell degranulation (GO:0043304) | 2.52905695 |
| 80 | negative regulation of bone resorption (GO:0045779) | 2.52665567 |
| 81 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.51859841 |
| 82 | detection of molecule of bacterial origin (GO:0032490) | 2.51177857 |
| 83 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.51128879 |
| 84 | regulation of interleukin-12 production (GO:0032655) | 2.49837213 |
| 85 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.49589691 |
| 86 | modulation by symbiont of host immune response (GO:0052553) | 2.49589691 |
| 87 | positive regulation by symbiont of host defense response (GO:0052509) | 2.49589691 |
| 88 | modulation by symbiont of host defense response (GO:0052031) | 2.49589691 |
| 89 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.49589691 |
| 90 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.49589691 |
| 91 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.49356000 |
| 92 | T cell selection (GO:0045058) | 2.49208638 |
| 93 | regulation of memory T cell differentiation (GO:0043380) | 2.49169370 |
| 94 | positive regulation of mast cell degranulation (GO:0043306) | 2.48985143 |
| 95 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.48985143 |
| 96 | negative regulation of stress fiber assembly (GO:0051497) | 2.41858581 |
| 97 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.40712505 |
| 98 | response to type I interferon (GO:0034340) | 2.39586097 |
| 99 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.38777395 |
| 100 | T-helper 1 type immune response (GO:0042088) | 2.38463489 |
| 101 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.37704544 |
| 102 | macrophage activation involved in immune response (GO:0002281) | 2.35189399 |
| 103 | keratan sulfate catabolic process (GO:0042340) | 2.35043152 |
| 104 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.34414351 |
| 105 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.33222967 |
| 106 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.33100551 |
| 107 | cellular response to type I interferon (GO:0071357) | 2.31673114 |
| 108 | type I interferon signaling pathway (GO:0060337) | 2.31673114 |
| 109 | endosome to melanosome transport (GO:0035646) | 2.30194213 |
| 110 | endosome to pigment granule transport (GO:0043485) | 2.30194213 |
| 111 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.29512975 |
| 112 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.27814125 |
| 113 | response to laminar fluid shear stress (GO:0034616) | 2.27450205 |
| 114 | positive regulation of B cell differentiation (GO:0045579) | 2.27444891 |
| 115 | toxin transport (GO:1901998) | 2.26803127 |
| 116 | gland morphogenesis (GO:0022612) | 2.26762501 |
| 117 | detection of other organism (GO:0098543) | 2.26472580 |
| 118 | cellular response to zinc ion (GO:0071294) | 2.24858699 |
| 119 | regulation of skeletal muscle contraction (GO:0014819) | 2.23508534 |
| 120 | positive regulation of macrophage cytokine production (GO:0060907) | 2.23052968 |
| 121 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.22088935 |
| 122 | detection of external biotic stimulus (GO:0098581) | 2.21463005 |
| 123 | positive regulation of cholesterol efflux (GO:0010875) | 2.20944117 |
| 124 | blood vessel maturation (GO:0001955) | 2.20279737 |
| 125 | response to interferon-beta (GO:0035456) | 2.18187826 |
| 126 | regulation of B cell differentiation (GO:0045577) | 2.17800580 |
| 127 | negative regulation of granulocyte differentiation (GO:0030853) | 2.17243635 |
| 128 | positive regulation of antigen processing and presentation (GO:0002579) | 2.15692156 |
| 129 | venous blood vessel morphogenesis (GO:0048845) | 2.14872630 |
| 130 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.14594027 |
| 131 | regulation of macrophage cytokine production (GO:0010935) | 2.14203181 |
| 132 | neutrophil activation involved in immune response (GO:0002283) | 2.12355631 |
| 133 | positive regulation of macrophage differentiation (GO:0045651) | 2.12320394 |
| 134 | pinocytosis (GO:0006907) | 2.10473189 |
| 135 | cell adhesion mediated by integrin (GO:0033627) | 2.09730960 |
| 136 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.07985740 |
| 137 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.07653846 |
| 138 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.07394303 |
| 139 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.06929481 |
| 140 | cellular response to interferon-alpha (GO:0035457) | 2.06663544 |
| 141 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.06655121 |
| 142 | response to fluid shear stress (GO:0034405) | 2.06453754 |
| 143 | negative regulation of protein autophosphorylation (GO:0031953) | 2.06028025 |
| 144 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.04964610 |
| 145 | microglial cell activation (GO:0001774) | 2.02102553 |
| 146 | positive regulation of sterol transport (GO:0032373) | 2.01963365 |
| 147 | positive regulation of cholesterol transport (GO:0032376) | 2.01963365 |
| 148 | growth hormone receptor signaling pathway (GO:0060396) | 2.01198050 |
| 149 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.00392127 |
| 150 | platelet dense granule organization (GO:0060155) | 1.99241191 |
| 151 | cell differentiation involved in metanephros development (GO:0072202) | 1.98770536 |
| 152 | positive regulation of chemokine secretion (GO:0090197) | 1.98670236 |
| 153 | cellular response to growth hormone stimulus (GO:0071378) | 1.97117982 |
| 154 | apoptotic cell clearance (GO:0043277) | 1.96911788 |
| 155 | germ cell migration (GO:0008354) | 1.96195550 |
| 156 | negative regulation of biomineral tissue development (GO:0070168) | 1.96143224 |
| 157 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 1.93954260 |
| 158 | regulation of interleukin-8 secretion (GO:2000482) | 1.93838420 |
| 159 | detection of biotic stimulus (GO:0009595) | 1.92788451 |
| 160 | response to host immune response (GO:0052572) | 1.92684404 |
| 161 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 1.92684404 |
| 162 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 1.91931397 |
| 163 | positive regulation of natural killer cell activation (GO:0032816) | 1.91685417 |
| 164 | response to nitrosative stress (GO:0051409) | 1.91640940 |
| 165 | positive regulation of respiratory burst (GO:0060267) | 1.91548973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.66869985 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.41770599 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.09033096 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.43412968 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.22166453 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.63476986 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.60966213 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.57190440 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.56285205 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.56061950 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.44587774 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.35804342 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.28283810 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.22364705 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.21709023 |
| 16 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20771972 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.18677903 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.17784034 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.17720179 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15204617 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.08253155 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.07798394 |
| 23 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.05926300 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.00890632 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.96541265 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.90325680 |
| 27 | GATA3_26560356_Chip-Seq_TH2_Human | 1.87567325 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82362349 |
| 29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.82096687 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76434734 |
| 31 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73617291 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.71956346 |
| 33 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.71594701 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.71188343 |
| 35 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.70288112 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.68138174 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.67698599 |
| 38 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.67698599 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.66706246 |
| 40 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66206411 |
| 41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.64804211 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.61461606 |
| 43 | CJUN_26792858_Chip-Seq_BT549_Human | 1.61042566 |
| 44 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.55401224 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54333270 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53834990 |
| 47 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53461312 |
| 48 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.52120472 |
| 49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51007597 |
| 50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.49637973 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49017312 |
| 52 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.46381140 |
| 53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.45817317 |
| 54 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.41600474 |
| 55 | * MYB_26560356_Chip-Seq_TH2_Human | 1.37803453 |
| 56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37557579 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36375535 |
| 58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.36027549 |
| 59 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.34100437 |
| 60 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31266262 |
| 61 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.29909149 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.29560115 |
| 63 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.28505541 |
| 64 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.26638774 |
| 65 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25793976 |
| 66 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25793976 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24437789 |
| 68 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.23157291 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20786036 |
| 70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18547627 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17489831 |
| 72 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13829510 |
| 73 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.13795568 |
| 74 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.13180312 |
| 75 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11295760 |
| 76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11047489 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.09752260 |
| 78 | MAF_26560356_Chip-Seq_TH1_Human | 1.09731694 |
| 79 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09054134 |
| 80 | MYB_26560356_Chip-Seq_TH1_Human | 1.07937966 |
| 81 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07365591 |
| 82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07023082 |
| 83 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.06920249 |
| 84 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06714147 |
| 85 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.05955263 |
| 86 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02869104 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02848927 |
| 88 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02505562 |
| 89 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.01879680 |
| 90 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01019164 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00886197 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00810248 |
| 93 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00327984 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98850146 |
| 95 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98654647 |
| 96 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98126598 |
| 97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97944641 |
| 98 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97908518 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97908518 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97842608 |
| 101 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97750318 |
| 102 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96761177 |
| 103 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95762452 |
| 104 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.95692288 |
| 105 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95108245 |
| 106 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94767392 |
| 107 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94371798 |
| 108 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94359896 |
| 109 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.94058649 |
| 110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93944351 |
| 111 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.93386521 |
| 112 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.92705428 |
| 113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92271835 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91731207 |
| 115 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.88700528 |
| 116 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.88589920 |
| 117 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.88030568 |
| 118 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.87970109 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87738132 |
| 120 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87023752 |
| 121 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87020985 |
| 122 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85950693 |
| 123 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85029840 |
| 124 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83678125 |
| 125 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83525729 |
| 126 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.83468404 |
| 127 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.83324327 |
| 128 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.83190983 |
| 129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82863467 |
| 130 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82794240 |
| 131 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.82031597 |
| 132 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.81158582 |
| 133 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81050705 |
| 134 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81018316 |
| 135 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80426994 |
| 136 | MAF_26560356_Chip-Seq_TH2_Human | 0.80350847 |
| 137 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.79428983 |
| 138 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.76920913 |
| 139 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76918506 |
| 140 | TP53_16413492_ChIP-PET_HCT116_Human | 0.76271349 |
| 141 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.76136710 |
| 142 | GATA3_26560356_Chip-Seq_TH1_Human | 0.76133356 |
| 143 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76072868 |
| 144 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.75974597 |
| 145 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.75941702 |
| 146 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.75604896 |
| 147 | VDR_22108803_ChIP-Seq_LS180_Human | 0.74484073 |
| 148 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73417559 |
| 149 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.73214899 |
| 150 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.73095364 |
| 151 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71602161 |
| 152 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.71121700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.59958681 |
| 2 | MP0003303_peritoneal_inflammation | 2.65095649 |
| 3 | MP0002166_altered_tumor_susceptibility | 2.59032104 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.49930876 |
| 5 | MP0005275_abnormal_skin_tensile | 2.46208860 |
| 6 | MP0001879_abnormal_lymphatic_vessel | 2.38442734 |
| 7 | MP0003724_increased_susceptibility_to | 2.26508049 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.19170805 |
| 9 | MP0002006_tumorigenesis | 2.12260987 |
| 10 | MP0009785_altered_susceptibility_to | 1.99273060 |
| 11 | MP0003279_aneurysm | 1.98030788 |
| 12 | MP0009384_cardiac_valve_regurgitation | 1.95324609 |
| 13 | MP0006082_CNS_inflammation | 1.87632706 |
| 14 | MP0000685_abnormal_immune_system | 1.82589644 |
| 15 | MP0005310_abnormal_salivary_gland | 1.82057516 |
| 16 | MP0000569_abnormal_digit_pigmentation | 1.79952719 |
| 17 | MP0005503_abnormal_tendon_morphology | 1.76105222 |
| 18 | MP0001958_emphysema | 1.75130226 |
| 19 | MP0005671_abnormal_response_to | 1.71191540 |
| 20 | MP0010368_abnormal_lymphatic_system | 1.70425797 |
| 21 | MP0002419_abnormal_innate_immunity | 1.69496577 |
| 22 | MP0005058_abnormal_lysosome_morphology | 1.69077758 |
| 23 | MP0003436_decreased_susceptibility_to | 1.68911850 |
| 24 | MP0002009_preneoplasia | 1.65903218 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.60762382 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.57168014 |
| 27 | MP0002933_joint_inflammation | 1.54958030 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.54327572 |
| 29 | MP0006054_spinal_hemorrhage | 1.51535808 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.51201345 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.50237605 |
| 32 | MP0005025_abnormal_response_to | 1.49388931 |
| 33 | MP0001790_abnormal_immune_system | 1.47840793 |
| 34 | MP0005387_immune_system_phenotype | 1.47840793 |
| 35 | MP0004947_skin_inflammation | 1.45041156 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.44583743 |
| 37 | MP0009764_decreased_sensitivity_to | 1.43318546 |
| 38 | MP0002060_abnormal_skin_morphology | 1.42526581 |
| 39 | MP0004130_abnormal_muscle_cell | 1.40349024 |
| 40 | MP0002998_abnormal_bone_remodeling | 1.40070703 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.37953767 |
| 42 | * MP0002452_abnormal_antigen_presenting | 1.36947176 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.34595000 |
| 44 | MP0000343_altered_response_to | 1.31730630 |
| 45 | MP0003690_abnormal_glial_cell | 1.30698819 |
| 46 | MP0003763_abnormal_thymus_physiology | 1.29069499 |
| 47 | MP0004272_abnormal_basement_membrane | 1.28595089 |
| 48 | MP0001853_heart_inflammation | 1.27412410 |
| 49 | MP0001800_abnormal_humoral_immune | 1.27386033 |
| 50 | MP0002396_abnormal_hematopoietic_system | 1.26764740 |
| 51 | MP0004808_abnormal_hematopoietic_stem | 1.26477340 |
| 52 | MP0002723_abnormal_immune_serum | 1.24808502 |
| 53 | MP0003866_abnormal_defecation | 1.24253108 |
| 54 | * MP0002429_abnormal_blood_cell | 1.24147751 |
| 55 | MP0003566_abnormal_cell_adhesion | 1.23798042 |
| 56 | MP0009278_abnormal_bone_marrow | 1.23370558 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.20947094 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.20868211 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.20868211 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.20673781 |
| 61 | MP0002877_abnormal_melanocyte_morpholog | 1.18632564 |
| 62 | MP0002420_abnormal_adaptive_immunity | 1.17710228 |
| 63 | MP0002132_abnormal_respiratory_system | 1.17643849 |
| 64 | MP0010386_abnormal_urinary_bladder | 1.17258513 |
| 65 | MP0001819_abnormal_immune_cell | 1.16228093 |
| 66 | MP0002254_reproductive_system_inflammat | 1.16191385 |
| 67 | MP0002295_abnormal_pulmonary_circulatio | 1.15212895 |
| 68 | MP0002405_respiratory_system_inflammati | 1.12994362 |
| 69 | MP0005670_abnormal_white_adipose | 1.11994761 |
| 70 | MP0003828_pulmonary_edema | 1.11154363 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.10618160 |
| 72 | MP0005023_abnormal_wound_healing | 1.10169798 |
| 73 | MP0000767_abnormal_smooth_muscle | 1.07977202 |
| 74 | MP0005390_skeleton_phenotype | 1.06730551 |
| 75 | MP0002693_abnormal_pancreas_physiology | 1.05685876 |
| 76 | MP0003075_altered_response_to | 1.05676849 |
| 77 | MP0005164_abnormal_response_to | 1.05562298 |
| 78 | MP0003186_abnormal_redox_activity | 1.03158830 |
| 79 | MP0000604_amyloidosis | 1.02899221 |
| 80 | MP0008469_abnormal_protein_level | 1.02563849 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 1.00721880 |
| 82 | MP0003705_abnormal_hypodermis_morpholog | 1.00282954 |
| 83 | MP0002876_abnormal_thyroid_physiology | 0.99250271 |
| 84 | MP0002277_abnormal_respiratory_mucosa | 0.98709349 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.98563594 |
| 86 | MP0003172_abnormal_lysosome_physiology | 0.94802346 |
| 87 | MP0005508_abnormal_skeleton_morphology | 0.93999260 |
| 88 | MP0009840_abnormal_foam_cell | 0.92245619 |
| 89 | MP0000372_irregular_coat_pigmentation | 0.91219093 |
| 90 | MP0003806_abnormal_nucleotide_metabolis | 0.90715299 |
| 91 | MP0003252_abnormal_bile_duct | 0.90436195 |
| 92 | MP0000703_abnormal_thymus_morphology | 0.90172427 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.86976836 |
| 94 | MP0008004_abnormal_stomach_pH | 0.86677937 |
| 95 | MP0003795_abnormal_bone_structure | 0.86210938 |
| 96 | MP0003011_delayed_dark_adaptation | 0.85567680 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.85472594 |
| 98 | MP0009763_increased_sensitivity_to | 0.84792497 |
| 99 | MP0001851_eye_inflammation | 0.84514354 |
| 100 | MP0005166_decreased_susceptibility_to | 0.84444610 |
| 101 | MP0003448_altered_tumor_morphology | 0.84396757 |
| 102 | MP0003646_muscle_fatigue | 0.83708518 |
| 103 | MP0000249_abnormal_blood_vessel | 0.82890355 |
| 104 | * MP0000716_abnormal_immune_system | 0.82339969 |
| 105 | MP0003943_abnormal_hepatobiliary_system | 0.81177291 |
| 106 | MP0003045_fibrosis | 0.80194903 |
| 107 | MP0008875_abnormal_xenobiotic_pharmacok | 0.79843318 |
| 108 | MP0000858_altered_metastatic_potential | 0.79008671 |
| 109 | MP0004381_abnormal_hair_follicle | 0.78572638 |
| 110 | MP0000733_abnormal_muscle_development | 0.78356552 |
| 111 | MP0001663_abnormal_digestive_system | 0.78194828 |
| 112 | MP0001849_ear_inflammation | 0.77829343 |
| 113 | MP0004883_abnormal_blood_vessel | 0.76844865 |
| 114 | MP0005075_abnormal_melanosome_morpholog | 0.75899728 |
| 115 | MP0000371_diluted_coat_color | 0.75535764 |
| 116 | MP0002398_abnormal_bone_marrow | 0.75207955 |
| 117 | MP0002168_other_aberrant_phenotype | 0.74413774 |
| 118 | MP0000383_abnormal_hair_follicle | 0.74127209 |
| 119 | MP0003195_calcinosis | 0.73947956 |
| 120 | MP0005085_abnormal_gallbladder_physiolo | 0.73790300 |
| 121 | MP0000689_abnormal_spleen_morphology | 0.72984856 |
| 122 | MP0001873_stomach_inflammation | 0.72228951 |
| 123 | MP0005365_abnormal_bile_salt | 0.71072011 |
| 124 | MP0000427_abnormal_hair_cycle | 0.71035123 |
| 125 | MP0002722_abnormal_immune_system | 0.70740025 |
| 126 | MP0009250_abnormal_appendicular_skeleto | 0.70173712 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 0.69819967 |
| 128 | MP0002136_abnormal_kidney_physiology | 0.67850223 |
| 129 | MP0004043_abnormal_pH_regulation | 0.64978745 |
| 130 | MP0009643_abnormal_urine_homeostasis | 0.63381192 |
| 131 | MP0002102_abnormal_ear_morphology | 0.63202495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.59269274 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.59269274 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.59269274 |
| 4 | Stomatitis (HP:0010280) | 4.23045370 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.91149296 |
| 6 | Recurrent cutaneous fungal infections (HP:0011370) | 3.56528707 |
| 7 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.56528707 |
| 8 | Pulmonary infiltrates (HP:0002113) | 3.11053168 |
| 9 | Aortic aneurysm (HP:0004942) | 3.09601019 |
| 10 | Vasculitis (HP:0002633) | 3.09433222 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.08400016 |
| 12 | Recurrent abscess formation (HP:0002722) | 3.01224108 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.01090170 |
| 14 | Protrusio acetabuli (HP:0003179) | 2.99839247 |
| 15 | Broad metatarsal (HP:0001783) | 2.99688382 |
| 16 | Eczematoid dermatitis (HP:0000976) | 2.97658745 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 2.97341581 |
| 18 | Hemoptysis (HP:0002105) | 2.94212966 |
| 19 | Myositis (HP:0100614) | 2.92764203 |
| 20 | Keratoconjunctivitis (HP:0001096) | 2.85618571 |
| 21 | Hematochezia (HP:0002573) | 2.85486428 |
| 22 | T lymphocytopenia (HP:0005403) | 2.85196207 |
| 23 | Encephalitis (HP:0002383) | 2.84175099 |
| 24 | Abnormality of T cell number (HP:0011839) | 2.84031791 |
| 25 | Chronic otitis media (HP:0000389) | 2.81402911 |
| 26 | Aortic dissection (HP:0002647) | 2.80757183 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 2.72950929 |
| 28 | Orchitis (HP:0100796) | 2.71937332 |
| 29 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.69017893 |
| 30 | Dysostosis multiplex (HP:0000943) | 2.65687944 |
| 31 | Spontaneous hematomas (HP:0007420) | 2.62049054 |
| 32 | Abnormality of macrophages (HP:0004311) | 2.60535804 |
| 33 | Hypoplasia of the thymus (HP:0000778) | 2.60230185 |
| 34 | Increased IgM level (HP:0003496) | 2.55733097 |
| 35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.54244492 |
| 36 | Recurrent viral infections (HP:0004429) | 2.50260593 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.41987115 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.37481151 |
| 39 | Obstructive lung disease (HP:0006536) | 2.37481151 |
| 40 | Mucopolysacchariduria (HP:0008155) | 2.36450400 |
| 41 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.36450400 |
| 42 | Gingivitis (HP:0000230) | 2.35189440 |
| 43 | Urticaria (HP:0001025) | 2.33790174 |
| 44 | Vascular tortuosity (HP:0004948) | 2.32819221 |
| 45 | Hypoproteinemia (HP:0003075) | 2.26647296 |
| 46 | Thyroiditis (HP:0100646) | 2.26487288 |
| 47 | Chronic diarrhea (HP:0002028) | 2.24586149 |
| 48 | Chronic sinusitis (HP:0011109) | 2.24563588 |
| 49 | Eosinophilia (HP:0001880) | 2.24219372 |
| 50 | Spondylolisthesis (HP:0003302) | 2.22137202 |
| 51 | Loss of speech (HP:0002371) | 2.21374507 |
| 52 | Autoimmune thrombocytopenia (HP:0001973) | 2.20184480 |
| 53 | Agammaglobulinemia (HP:0004432) | 2.19065959 |
| 54 | IgG deficiency (HP:0004315) | 2.18733254 |
| 55 | Recurrent fungal infections (HP:0002841) | 2.18644972 |
| 56 | Abnormality of B cell number (HP:0010975) | 2.17383151 |
| 57 | B lymphocytopenia (HP:0010976) | 2.17383151 |
| 58 | Cheilitis (HP:0100825) | 2.17256261 |
| 59 | Hypergammaglobulinemia (HP:0010702) | 2.16709018 |
| 60 | Arterial tortuosity (HP:0005116) | 2.16661651 |
| 61 | Gingival bleeding (HP:0000225) | 2.16533311 |
| 62 | Premature rupture of membranes (HP:0001788) | 2.15382669 |
| 63 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.15045481 |
| 64 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.15045481 |
| 65 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.15045481 |
| 66 | Chest pain (HP:0100749) | 2.14451619 |
| 67 | Anorexia (HP:0002039) | 2.14183452 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.12475750 |
| 69 | Prolonged bleeding time (HP:0003010) | 2.10490125 |
| 70 | Systemic lupus erythematosus (HP:0002725) | 2.09857701 |
| 71 | Type 1 muscle fiber predominance (HP:0003803) | 2.09703495 |
| 72 | Vertebral compression fractures (HP:0002953) | 2.09009766 |
| 73 | Increased IgE level (HP:0003212) | 2.08982676 |
| 74 | Pulmonary embolism (HP:0002204) | 2.08165552 |
| 75 | Optic neuritis (HP:0100653) | 2.08156649 |
| 76 | Retrobulbar optic neuritis (HP:0100654) | 2.08156649 |
| 77 | Periodontitis (HP:0000704) | 2.08141284 |
| 78 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.07649725 |
| 79 | Gangrene (HP:0100758) | 2.07412093 |
| 80 | Abnormality of the nasal mucosa (HP:0000433) | 2.07116953 |
| 81 | Arterial thrombosis (HP:0004420) | 2.06695150 |
| 82 | Osteolytic defects of the hand bones (HP:0009699) | 2.05506089 |
| 83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05506089 |
| 84 | Congenital stationary night blindness (HP:0007642) | 2.04375559 |
| 85 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.04036639 |
| 86 | Hypochromic anemia (HP:0001931) | 2.03826988 |
| 87 | Cerebral aneurysm (HP:0004944) | 2.02073237 |
| 88 | Decreased circulating renin level (HP:0003351) | 2.02010408 |
| 89 | Atrophic scars (HP:0001075) | 2.01623290 |
| 90 | Broad face (HP:0000283) | 2.01000459 |
| 91 | Global brain atrophy (HP:0002283) | 2.00804731 |
| 92 | Abnormality of the pleura (HP:0002103) | 2.00414573 |
| 93 | Abnormality of secondary sexual hair (HP:0009888) | 1.99199878 |
| 94 | Abnormality of the axillary hair (HP:0100134) | 1.99199878 |
| 95 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98661085 |
| 96 | Abnormality of the prostate (HP:0008775) | 1.98089883 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 1.97160844 |
| 98 | Beaking of vertebral bodies (HP:0004568) | 1.96970147 |
| 99 | Panhypogammaglobulinemia (HP:0003139) | 1.96924828 |
| 100 | Abnormality of T cells (HP:0002843) | 1.96097372 |
| 101 | Increased serum ferritin (HP:0003281) | 1.93884106 |
| 102 | Recurrent sinusitis (HP:0011108) | 1.93393449 |
| 103 | Keratitis (HP:0000491) | 1.93323271 |
| 104 | Inflammation of the large intestine (HP:0002037) | 1.92667455 |
| 105 | Epistaxis (HP:0000421) | 1.92448123 |
| 106 | Episodic fever (HP:0001954) | 1.91809960 |
| 107 | Cervical subluxation (HP:0003308) | 1.90933645 |
| 108 | Congenital, generalized hypertrichosis (HP:0004540) | 1.90178975 |
| 109 | Abnormality of the lumbar spine (HP:0100712) | 1.89729632 |
| 110 | Short hallux (HP:0010109) | 1.89670436 |
| 111 | Prostate neoplasm (HP:0100787) | 1.89178066 |
| 112 | Interstitial pulmonary disease (HP:0006530) | 1.88668078 |
| 113 | Increased CSF protein (HP:0002922) | 1.86347675 |
| 114 | Myocardial infarction (HP:0001658) | 1.86321301 |
| 115 | Leukocytosis (HP:0001974) | 1.86145041 |
| 116 | Asymmetric septal hypertrophy (HP:0001670) | 1.84720425 |
| 117 | Attenuation of retinal blood vessels (HP:0007843) | 1.84668729 |
| 118 | Peritonitis (HP:0002586) | 1.83348153 |
| 119 | Pustule (HP:0200039) | 1.82819858 |
| 120 | Abolished electroretinogram (ERG) (HP:0000550) | 1.82505809 |
| 121 | Tarsal synostosis (HP:0008368) | 1.82062949 |
| 122 | Joint swelling (HP:0001386) | 1.81448143 |
| 123 | Granulocytopenia (HP:0001913) | 1.80441674 |
| 124 | Nephritis (HP:0000123) | 1.80160457 |
| 125 | Recurrent skin infections (HP:0001581) | 1.78653779 |
| 126 | Polyneuropathy (HP:0001271) | 1.77714396 |
| 127 | Lip pit (HP:0100267) | 1.77407768 |
| 128 | Abnormality of eosinophils (HP:0001879) | 1.76887372 |
| 129 | Stomach cancer (HP:0012126) | 1.75678202 |
| 130 | Keratoconjunctivitis sicca (HP:0001097) | 1.75244943 |
| 131 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.72571363 |
| 132 | Biconcave vertebral bodies (HP:0004586) | 1.71082564 |
| 133 | Cellulitis (HP:0100658) | 1.70591897 |
| 134 | Tetraparesis (HP:0002273) | 1.70169668 |
| 135 | Increased cerebral lipofuscin (HP:0011813) | 1.69256806 |
| 136 | Mesangial abnormality (HP:0001966) | 1.69215407 |
| 137 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.68109472 |
| 138 | Craniofacial hyperostosis (HP:0004493) | 1.67861868 |
| 139 | Facial diplegia (HP:0001349) | 1.66886673 |
| 140 | Abnormality of the nasal septum (HP:0000419) | 1.65851319 |
| 141 | Hydroxyprolinuria (HP:0003080) | 1.65638885 |
| 142 | Abnormality of proline metabolism (HP:0010907) | 1.65638885 |
| 143 | Glomerulonephritis (HP:0000099) | 1.64358588 |
| 144 | Autoimmune hemolytic anemia (HP:0001890) | 1.63848521 |
| 145 | Hyperlipoproteinemia (HP:0010980) | 1.63637236 |
| 146 | Recurrent bronchitis (HP:0002837) | 1.63591109 |
| 147 | Thrombocytosis (HP:0001894) | 1.63376966 |
| 148 | Subacute progressive viral hepatitis (HP:0006572) | 1.63245867 |
| 149 | Follicular hyperkeratosis (HP:0007502) | 1.62708657 |
| 150 | Meningitis (HP:0001287) | 1.62290022 |
| 151 | Cardiovascular calcification (HP:0011915) | 1.61982624 |
| 152 | Purpura (HP:0000979) | 1.61513836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 3.60870928 |
| 2 | ADRBK2 | 2.38151071 |
| 3 | KIT | 2.30968538 |
| 4 | ERN1 | 2.26573463 |
| 5 | SIK1 | 2.15953710 |
| 6 | JAK3 | 2.14828533 |
| 7 | FRK | 2.12829773 |
| 8 | ACVR1B | 2.09425698 |
| 9 | TXK | 2.08430706 |
| 10 | TRIB3 | 1.96231884 |
| 11 | MAP3K14 | 1.84619440 |
| 12 | MAPK15 | 1.84517891 |
| 13 | CAMK1D | 1.82117846 |
| 14 | TEC | 1.77995677 |
| 15 | MYLK | 1.68273605 |
| 16 | MAP4K1 | 1.66298264 |
| 17 | BLK | 1.63581317 |
| 18 | FLT3 | 1.62389404 |
| 19 | TYK2 | 1.61792015 |
| 20 | FES | 1.60234301 |
| 21 | MAP2K3 | 1.56140642 |
| 22 | BTK | 1.55846700 |
| 23 | TTN | 1.55274193 |
| 24 | TIE1 | 1.54406972 |
| 25 | EPHA3 | 1.53723492 |
| 26 | LRRK2 | 1.52325901 |
| 27 | STK10 | 1.51881575 |
| 28 | NUAK1 | 1.50321545 |
| 29 | ZAP70 | 1.42998209 |
| 30 | FGFR4 | 1.42331054 |
| 31 | IKBKE | 1.42305965 |
| 32 | PKN2 | 1.41786585 |
| 33 | TBK1 | 1.38059312 |
| 34 | TRPM7 | 1.37871155 |
| 35 | FGFR3 | 1.36867708 |
| 36 | PIK3CG | 1.35383827 |
| 37 | INSRR | 1.34733595 |
| 38 | NME2 | 1.32309199 |
| 39 | JAK1 | 1.32305326 |
| 40 | PIM2 | 1.31834008 |
| 41 | GRK6 | 1.30547139 |
| 42 | DAPK2 | 1.29553091 |
| 43 | IRAK1 | 1.29512250 |
| 44 | TLK1 | 1.23017831 |
| 45 | MST4 | 1.22774672 |
| 46 | NEK9 | 1.20868897 |
| 47 | RIPK1 | 1.18598614 |
| 48 | MAP3K3 | 1.15991868 |
| 49 | ITK | 1.14911228 |
| 50 | IRAK4 | 1.11190530 |
| 51 | CAMKK2 | 1.10966637 |
| 52 | CSF1R | 1.10666183 |
| 53 | NLK | 1.06629486 |
| 54 | TGFBR1 | 1.05127290 |
| 55 | FGR | 1.04315469 |
| 56 | IKBKB | 1.04277222 |
| 57 | CSK | 1.00125375 |
| 58 | FGFR2 | 0.98849438 |
| 59 | GRK1 | 0.98105631 |
| 60 | SYK | 0.96545747 |
| 61 | CAMK1G | 0.96456570 |
| 62 | PTK2B | 0.96150316 |
| 63 | EPHB1 | 0.95670486 |
| 64 | ZAK | 0.95401221 |
| 65 | PDGFRB | 0.95332238 |
| 66 | MAP2K6 | 0.94706106 |
| 67 | KDR | 0.93085302 |
| 68 | MAP3K7 | 0.92762974 |
| 69 | DDR2 | 0.92552133 |
| 70 | MST1R | 0.88264542 |
| 71 | CDK6 | 0.87258865 |
| 72 | LCK | 0.86493507 |
| 73 | TNK2 | 0.85565723 |
| 74 | RIPK4 | 0.83969246 |
| 75 | ADRBK1 | 0.83821003 |
| 76 | MAPK7 | 0.83291464 |
| 77 | GRK7 | 0.83243897 |
| 78 | PTK6 | 0.83056637 |
| 79 | PDK1 | 0.82576368 |
| 80 | PDGFRA | 0.82092735 |
| 81 | IRAK3 | 0.82056166 |
| 82 | PINK1 | 0.82043072 |
| 83 | PIK3CA | 0.80269953 |
| 84 | MAPKAPK3 | 0.79848702 |
| 85 | MARK3 | 0.78887288 |
| 86 | ERBB3 | 0.78387265 |
| 87 | HCK | 0.77519724 |
| 88 | DMPK | 0.77216636 |
| 89 | JAK2 | 0.76937309 |
| 90 | LMTK2 | 0.76185114 |
| 91 | BMPR1B | 0.75882114 |
| 92 | OBSCN | 0.75397669 |
| 93 | EEF2K | 0.74673289 |
| 94 | CDC42BPA | 0.74506293 |
| 95 | TAOK3 | 0.74491665 |
| 96 | CHUK | 0.73690305 |
| 97 | RPS6KA4 | 0.72982038 |
| 98 | YES1 | 0.71972121 |
| 99 | BCKDK | 0.65581226 |
| 100 | LYN | 0.65100877 |
| 101 | MAP3K13 | 0.64805323 |
| 102 | MAPK12 | 0.64368056 |
| 103 | MATK | 0.63849434 |
| 104 | HIPK2 | 0.60201246 |
| 105 | PRKD2 | 0.58484045 |
| 106 | STK11 | 0.58096191 |
| 107 | MAPK11 | 0.57294656 |
| 108 | MAP3K1 | 0.56870715 |
| 109 | PDPK1 | 0.56452933 |
| 110 | IGF1R | 0.56166904 |
| 111 | PAK2 | 0.55890205 |
| 112 | PRKAA2 | 0.55074681 |
| 113 | SIK2 | 0.53321283 |
| 114 | ABL1 | 0.52389256 |
| 115 | PIM1 | 0.52215183 |
| 116 | WNK1 | 0.51804822 |
| 117 | PRKCQ | 0.51670928 |
| 118 | OXSR1 | 0.50244746 |
| 119 | PRKCH | 0.50179331 |
| 120 | ILK | 0.49771554 |
| 121 | RPS6KA6 | 0.49666850 |
| 122 | EIF2AK2 | 0.48916172 |
| 123 | PRKG2 | 0.48450735 |
| 124 | GRK5 | 0.47208775 |
| 125 | STK24 | 0.46497287 |
| 126 | MAPK4 | 0.45306893 |
| 127 | MET | 0.44821023 |
| 128 | BMPR2 | 0.44305325 |
| 129 | WNK4 | 0.43292232 |
| 130 | MAP3K2 | 0.43181759 |
| 131 | PRPF4B | 0.42226933 |
| 132 | MAP3K11 | 0.41749382 |
| 133 | MELK | 0.40905351 |
| 134 | SGK2 | 0.40348255 |
| 135 | STK38 | 0.39428599 |
| 136 | MAPKAPK2 | 0.37583845 |
| 137 | PRKCD | 0.33942824 |
| 138 | MAP4K2 | 0.30812305 |
| 139 | MAPK13 | 0.30775868 |
| 140 | CAMKK1 | 0.30710547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.00878810 |
| 2 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.58903742 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.51852034 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.26909064 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.10043978 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.08533994 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.01251833 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.97614833 |
| 9 | Malaria_Homo sapiens_hsa05144 | 1.96795265 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.71582474 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.66279015 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63793318 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61983219 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60186477 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.53602829 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.51497565 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.49923396 |
| 18 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.46463805 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.45912952 |
| 20 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45110733 |
| 21 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.45029558 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.45024760 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.43523742 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.37759674 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36928603 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.33724548 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33110217 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.32954752 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.31201381 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.29146615 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.28656586 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28615589 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28308460 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27826341 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.27800978 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 1.23246492 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22624008 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22508887 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21332404 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.17241922 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16882662 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.15017323 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.13592873 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.09147555 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.09052900 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08507970 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 1.07899776 |
| 48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06357999 |
| 49 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04149538 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04094586 |
| 51 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.01711303 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01658440 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98865053 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 0.95564586 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93063292 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 0.92547556 |
| 57 | Peroxisome_Homo sapiens_hsa04146 | 0.91240834 |
| 58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.90784951 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90645222 |
| 60 | Adherens junction_Homo sapiens_hsa04520 | 0.90413743 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.89943033 |
| 62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.89521688 |
| 63 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.87052519 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.86787210 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85478852 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85134045 |
| 67 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.84601992 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.82501789 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82455738 |
| 70 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81842681 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81473212 |
| 72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81250630 |
| 73 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.81026098 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80120680 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78806761 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.78220227 |
| 77 | Influenza A_Homo sapiens_hsa05164 | 0.77538072 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76431190 |
| 79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.76202039 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.75796694 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75073930 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74364541 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.73913082 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73409728 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70980753 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70685849 |
| 87 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.70351395 |
| 88 | Prostate cancer_Homo sapiens_hsa05215 | 0.69677015 |
| 89 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68659276 |
| 90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67620263 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.67489980 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67360593 |
| 93 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.65088060 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.62442251 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.62077771 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.61718503 |
| 97 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60502543 |
| 98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59605482 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58656167 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58478095 |
| 101 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58379489 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.55899950 |
| 103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55773791 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53484801 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | 0.52955462 |
| 106 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.52292830 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50034694 |
| 108 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49614234 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49332640 |
| 110 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48618102 |
| 111 | Retinol metabolism_Homo sapiens_hsa00830 | 0.47911178 |
| 112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47851521 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47674309 |
| 114 | Allograft rejection_Homo sapiens_hsa05330 | 0.47379114 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47166100 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46611956 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45841174 |
| 118 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45324638 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44992742 |
| 120 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43555218 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41341836 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40053529 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39074393 |
| 124 | Phototransduction_Homo sapiens_hsa04744 | 0.36651702 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34084281 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30747282 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.29874637 |
| 128 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27944207 |
| 129 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.27905566 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.26951490 |
| 131 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.26346472 |
| 132 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.24778193 |
| 133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.20476470 |

